Summary

Metabolomics has emerged as a transformative discipline in nutritional epidemiology, enabling comprehensive analysis of small molecules in biological samples to provide objective measures of dietary exposure and metabolic response. By profiling endogenous and food-derived metabolites in blood, urine or tissues, researchers can overcome limitations of self-reported intake and uncover novel biomarkers of nutrient status, food consumption and pathway perturbations. High-throughput platforms such as nuclear magnetic resonance spectroscopy and mass spectrometry deliver broad metabolite coverage, while multivariate statistical and machine-learning approaches integrate metabolomic data with genetic, demographic and lifestyle variables. This integration allows identification of distinct metabolic phenotypes—or metabotypes—and stratification of individuals according to their metabolic responses to diet. Large-scale cohort studies and controlled feeding trials have begun to map population-level metabolic signatures linked to habitual diets and to establish causal links between specific nutrients and disease-related pathways. These advances carry global significance for prevention of cardiometabolic and other non-communicable diseases, offering potential for tailored dietary recommendations. Moving forward, standardisation of analytical workflows, rigorous biomarker validation and international data sharing will be essential to translate metabolomic findings into public health and clinical practice.

Research from Nature Portfolio

Recent investigations have applied lipidomics to quantify the effects of dietary fat quality on cardiometabolic risk. One study devised a multilipid score summarising changes in lipid metabolites when replacing saturated fats with unsaturated fats, finding that higher scores predicted substantial reductions in cardiovascular events and type 2 diabetes across diverse cohorts and clinical trials. Simplified lipid-based scores further identified individuals most likely to benefit from Mediterranean-style interventions, demonstrating the potential of lipidomic stratification in guiding dietary recommendations. In another large-scale analysis, nuclear magnetic resonance profiling of circulating lipids revealed that adherence to healthy dietary patterns correlated with higher degrees of fatty acid unsaturation and elevated polyunsaturated fatty acid ratios, which in turn were associated with lower cardiovascular risk. Together, these studies link dietary behaviours to specific lipidomic alterations and long-term health outcomes, reinforcing the role of metabolomic markers in nutritional epidemiology.

Metabolomics in Nutritional Epidemiology publication trend

The graph below shows the total number of articles in metabolomics in nutritional epidemiology across all publications each year (not limited to Nature Index journals).

Technical terms

Metabolomics: The large-scale study of small molecules (metabolites) within cells, tissues or organisms to characterise metabolic responses.

Biomarker: A measurable indicator of a biological state or condition, such as a molecule reflecting dietary intake or health risk.

Lipidome: The full complement of lipid species within a biological system, reflecting lipid metabolism and dietary fat intake.

Nuclear magnetic resonance spectroscopy: An analytical technique that identifies and quantifies metabolites based on their magnetic properties in a strong magnetic field.

Mass spectrometry: A method to detect and quantify metabolites by measuring mass-to-charge ratios of ionised molecules.

Metabotype: A distinct metabolic phenotype representing characteristic patterns of metabolite levels in response to genetic and environmental factors, including diet.

References

  1. Lipidome changes due to improved dietary fat quality inform cardiometabolic risk reduction and precision nutrition. Nature Medicine (2024).
  2. Role of metabolomics in the delivery of precision nutrition. Redox Biology (2023).
  3. Proteomic and Metabolomic Correlates of Healthy Dietary Patterns: The Framingham Heart Study. Nutrients (2020).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.